MYXOID LIPOSARCOMA
Clinical trials for MYXOID LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOID LIPOSARCOMA trials appear
Sign up with your email to follow new studies for MYXOID LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: experimental drug targets rare sarcomas
Disease control Recruiting nowThis early-stage study is testing whether a new drug called BTX-A51 is safe for people with advanced liposarcoma, a rare type of cancer. Researchers will give the drug to about 24 patients whose cancer has returned or spread, and monitor them closely for side effects. The study w…
Matched conditions: MYXOID LIPOSARCOMA
Phase: PHASE1 • Sponsor: Michael Wagner, MD • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug duo aims to halt aggressive fat tissue cancer
Disease control Recruiting nowThis study is testing whether combining two drugs, mirdametinib and palbociclib, is safe and effective for people with advanced liposarcoma that has spread, returned, or cannot be surgically removed. Researchers will first find the safest dose of mirdametinib to give with a fixed…
Matched conditions: MYXOID LIPOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Last-Chance cancer therapy offered when standard product fails specs
Disease control AVAILABLEThis program provides controlled access to a special version of a cell therapy (afami-cel) for patients with synovial sarcoma or myxoid liposarcoma when the standard manufactured product does not meet quality specifications. It is for patients who have already been prescribed thi…
Matched conditions: MYXOID LIPOSARCOMA
Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC